Levosimendan Improves Neurological Outcome in a Swine Model of Asphyxial Cardiac Arrest

Heart Lung and Circulation

Volumn 24, Issue 9, 2015, Pages 925-931

  Kosmidou, Maria Louiza ^a   Xanthos, Theodoros ^a,b   Chalkias, Athanasios ^a,b   Lelovas, Pavlos ^a   Varvarousi, Giolanda ^a   Lekka, Nektaria ^a   Lappas, Theodoros ^a   Papadimitriou, Lila ^a   Perrea, Despoina ^a   Dontas, Ismene ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic Society of Cardiopulmonary Resuscitation   (Greece)

Author keywords

Asphyxia; Cardiac arrest; Cardiopulmonary resuscitation; Levosimendan; Neurological outcome

Indexed keywords

ADRENALIN; LEVOSIMENDAN; PLACEBO; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPHYXIA; ASPHYXIAL CARDIAC ARREST; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; HEART ARREST; HEART HEMODYNAMICS; HEART RATE; MALE; NEUROLOGIC EXAMINATION; NONHUMAN; PIG; PRIORITY JOURNAL; RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; HEMODYNAMICS; PATHOPHYSIOLOGY;

ANIMALS; ASPHYXIA; DISEASE MODELS, ANIMAL; HEART ARREST; HEMODYNAMICS; HYDRAZONES; PYRIDAZINES; SWINE;

EID: 84940795507     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2015.02.024     Document Type: Article

References (42)

1. Wu C.J., Li C.S., Zhang Y., Yang J., Yin Q., Hang C.C. Differences of postresuscitation myocardial dysfunction in ventricular fibrillation versus asphyxiation. Am J Emerg Med 2013, 31:1690-1696.
2. Varvarousi G., Johnson E.O., Goulas S., Agrogiannis G., Valsamakis N., Perrea D., et al. Combination pharmacotherapy improves neurological outcome after asphyxial cardiac arrest. Resuscitation 2012, 83:527-532.
3. Stroumpoulis K., Xanthos T., Rokas G., Kitsou V., Papadimitriou D., Serpetinis I., et al. Vasopressin and epinephrine in the treatment of cardiac arrest: an experimental study. Crit Care 2008, 12:R40.
4. Mayr VD1, Wenzel V., Voelckel W.G., Krismer A.C., Mueller T., Lurie K.G., et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001, 104:1651-1656.
5. Chalkias A., Xanthos T. Post-cardiac arrest brain injury: pathophysiology and treatment. J Neurol Sci 2012, 315:1-8.
6. Follath F., Cleland J.G., Just H., Papp J.G., Scholz H., Peuhkurinen K., et al. Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low output heart failure (the LIDO study): a randomized double-blind trial. Lancet 2002, 360:196-202.
7. Slawsky M.T., Colucci W.S., Gottlieb S.S., Greenberg B.H., Haeusslein E., Hare J., et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000, 102:2222-2227.
8. Nieminen M.S., Akkila J., Hasenfuss G., Kleber F.X., Lehtonen L.A., Mitrovic V., et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 2000, 36:1903-1912.
9. Toller W., Algotsson L., Guarracino F., Hörmann C., Knotzer J., Lehmann A., et al. Perioperative use of levosimendan: best practice in operative settings. J Cardiothorac Vasc Anesth 2013, 27:361-366.
10. Koudouna E., Xanthos T., Bassiakou E., Goulas S., Lelovas P., Papadimitriou D., et al. Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest. Acta Anaesthesiol Scand 2007, 51:1123-1129.
11. Xanthos T., Bassiakou E., Koudouna E., Rokas G., Goulas S., Dontas I., et al. Combination pharmacotherapy in the treatment of experimental cardiac arrest. Am J Emerg Med 2009, 27:651-659.
12. Varvarousi G., Goulas S., Agrogiannis G., Valsamakis N., Iliopoulos D., Perrea D., et al. Epinephrine, vasopressin, and nitroglycerin improve neurologic outcome in porcine asphyxial cardiac arrest. Am J Emerg Med 2012, 30:1549-1554.
13. Xanthos T., Lelovas P., Vlachos I., Tsirikos-Karapanos N., Kouskouni E., Perrea D., et al. Cardiopulmonary arrest and resuscitation in Landrace/Large White swine: a research model. Lab Anim 2007, 41:353-362.
14. Deakin C.D., Nolan J.P., Soar J., Sunde K., Koster R.W., Smith G.B., et al. European resuscitation council guidelines for resuscitation 2010. Section 4. Adult advanced life support. Resuscitation 2010, 81:1305-1352.
15. Xanthos T., Bassiakou E., Koudouna E., Tsirikos-Karapanos N., Lelovas P., Papadimitriou D., et al. Baseline hemodynamics in anesthetized Landrace-Large White swine: reference values for research in cardiac arrest and cardiopulmonary resuscitation models. J Am Assoc Lab Anim Sci 2007, 46:21-25.
16. Swindle M.M., Volger G.A., Fulton L.K., Marini R.P., Popilskis S. Preanaesthesia, anesthesia, analgesia and euthanasia. Laboratory Animal Medicine 2002, 955-1003. Academic Press, New York. Second Edition. J.G. Fox, L.C. Anderson, F.M. Loew, F.W. Quimby (Eds.).
17. McCaul C.L., McNamara P.J., Engelberts D., Wilson G.J., Romaschin A., Redington A.N., et al. Epinephrine increases mortality after brief asphyxial cardiac arrest in an in vivo rat model. Anesth Analg 2006, 102:542-548.
18. López-Herce J., Fernández B., Urbano J., Mencía S., Solana M.J., Del Castillo J., et al. Correlations between hemodynamic, oxygenation and tissue perfusion parameters during asphyxial cardiac arrest and resuscitation in a pediatric animal model. Resuscitation 2011, 82:755-759.
19. Yokoshiki H., Katsube Y., Sunagawa M., Sperelakis N. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes. Eur J Pharmacol 1997, 333:249-259.
20. Kaheinen P., Pollesello P., Levijoki J., Haikala H. Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels. J Cardiovasc Pharmacol 2001, 37:367-374.
21. Erdei N., Papp Z., Pollesello P., Edes I., Bagi Z. The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles. Br J Pharmacol 2006, 148:696-702.
22. Varvarousi G., Xanthos T., Lappas T., Lekka N., Goulas S., Dontas I., et al. Asphyxial cardiac arrest, resuscitation and neurological outcome in a Landrace/Large-White swine model. Lab Anim 2011, 45:184-190.
23. Toller W., Wölkart G., Stranz C., Metzler H., Brunner F. Contractile action of levosimendan and epinephrine during acidosis. Eur J Pharmacol 2005, 507:199-209.
24. Chalkias A., Xanthos T. Pathophysiology and pathogenesis of post-resuscitation myocardial stunning. Heart Fail Rev 2012, 17:117-128.
25. Morelli A., Donati A., Ertmer C., Rehberg S., Lange M., Orecchioni A., et al. Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study. Crit Care 2010, 14:R232.
26. Haikala H., Kaivola J., Nissinen E., Wall P., Levijoki J., Lindén I.B. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 1995, 27:1859-1866.
27. Haikala H., Linden I.B. Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 1995, 26:10-19.
28. Pollesello P., Ovaska M., Kaivola J., Tilgmann C., Lundström K., Kalkkinen N., et al. Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 1994, 69:28584-28590.
29. Sorsa T., Pollesello P., Solaro R.J. The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. Mol Cell Biochem 2004, 266:87-107.
30. Morelli A., Ertmer C., Westphal M. Calcium sensitizing in sepsis: is levosimendan on the right path?. Crit Care Med 2008, 36:1981-1982.
31. Noto A., Giacomini M., Palandi A., Stabile L., Reali-Forster C., Iapichino G. Levosimendan in septic cardiac failure. Intensive Care Med 2005, 31:164-165.
32. Powell B.P., De Keulenaer B.L. Levosimendan in septic shock: a case series. Br J Anaesth 2007, 99:447-448.
33. Nieminen M.S., Fruhwald S., Heunks L.M., Suominen P.K., Gordon A.C., Kivikko M., et al. Levosimendan: current data, clinical use and future development. Heart Lung Vessel 2013, 5:227-245.
34. Kelm R.F., Wagenführer J., Bauer H., Schmidtmann I., Engelhard K., Noppens R.R. Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats. Crit Care Med 2014, 42:e410-e419.
35. Huang L., Weil M.H., Tang W., Sun S., Wang J. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction. Crit Care Med 2005, 33:487-491.
36. Lilleberg J., Sundberg S., Nieminen M.S. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J Cardiovasc Pharmacol 1995, 26:63-69.
37. Lilleberg J., Laine M., Palkama T., Kivikko M., Pohjanjousi P., Kupari M. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure. Eur J Heart Fail 2007, 9:75-82.
38. Hess E.P., Campbell R.L., White R.D. Epidemiology, trends and outcome of out-of-hospital cardiac arrest of non-cardiac origin. Resuscitation 2007, 72:200-206.
39. Donoghue A.J., Nadkarni V., Berg R.A., Osmond M.H., Wells G., Nesbitt L., et al. Out-of-hospital pediatric cardiac arrest: an epidemiologic review and assessment of current knowledge. Ann Emerg Med 2005, 46:512-522. CanAm Pediatric Cardiac Arrest Investigators.
40. Steen S., Liao Q., Pierre L., Paskevicius A., Sjöberg T. Evaluation of LUCAS, a new device for automatic mechanical compression and active decompression resuscitation. Resuscitation 2002, 55:285-299.
41. Hein M., Zoremba N., Bleilevens C., Bruells C., Rossaint R., Roehl A.B. Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model. BMC Neurol 2013, 13:106.
42. Morelli A., De Castro S., Teboul J.L., Singer M., Rocco M., Conti G., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005, 31:638-644.